22 Hrs
Source:
بوابة الفجر
Egyptian Drug Authority Visits Minhai for Vaccine Tech Deal
The Chairman of the Egyptian Drug Authority, Dr. Ali El-Ghamrawy, announced the signing of an agreement with the Chinese company Minhai to transfer the technology for manufacturing the Pneumococcal Vaccine PCV-20 to Egypt, with the aim of expanding cooperation and localizing vaccine technology. He also toured the PCV-13 vaccine production line and inspected the manufacturing processes, emphasizing the importance of strengthening partnerships with leading companies to support national manufacturing capabilities and achieve pharmaceutical security. These steps aim to develop Egypt's vaccine industry, enhance its competitive capacity, and facilitate exports to regional and international markets.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)